General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Inari Medical(SIGNIFICANT), Boston Scientific(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Endovascular Engineering(MODEST) OFFICER, DIRECTOR ETC: PERT Consortium(NONE), SCAI(NONE) RESEARCH/RESEARCH GRANTS: inari medical(NONE), Edwards (NONE)

View Full Disclosure